More articles from Review

Open Access
Long Non-coding RNAs Sponging MicroRNAs With Efficacy in Preclinical In Vivo Models of Esophageal Squamous Cell Cancer
ULRICH H. WEIDLE and ADAM NOPORA

Anticancer Research July 2022, 42 (7) 3233-3249; DOI: https://doi.org/10.21873/anticanres.15813
Open Access
Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations–State-of-the-Art
EVANGELOS DIMAKAKOS, GEORGIA GOMATOU, MARIELLA CATALANO, DAN-MIRCEA OLINIC, ALEX C. SPYROPOULOS, ANNA FALANGA, ANTHONY MARAVEYAS, AARON LIEW, SAM SCHULMAN, JILL BELCH, GRIGORIOS GEROTZIAFAS, PETER MARSCHANG, BENILDE COSMI, JONAS SPAAK, KONSTANTINOS SYRIGOS and CANCER-COVID-19 THROMBOSIS COLLABORATIVE GROUP, endorsed by VAS-European Independent Foundation in Angiology/Vascular Medicine, UEMS Vascular Medicine/Angiology and European Society of Vascular Medicine, and supported by the Balkan Working Group for Prevention and Treatment of Venous Thromboembolism and Hellenic Association of Lung Cancer

Anticancer Research July 2022, 42 (7) 3261-3274; DOI: https://doi.org/10.21873/anticanres.15815
Open Access
Postoperative Pancreatic Fistula: Is Minimally Invasive Surgery Better than Open? A Systematic Review and Meta-analysis
NICCOLO PETRUCCIANI, ANNA CROVETTO, FRANCESCA DE FELICE, MARCO PACE, DIEGO GIULITTI, MARCO YUSEF, GIUSEPPE NIGRI, STEFANO VALABREGA, RADWAN KASSIR, FRANCESCO D’ANGELO, TAREK DEBS, GIOVANNI RAMACCIATO and PAOLO AURELLO

Anticancer Research July 2022, 42 (7) 3285-3298; DOI: https://doi.org/10.21873/anticanres.15817
Open Access
Immunotherapy for Non-small Cell Lung Cancer: Current Agents and Potential Molecular Targets
NELSON OW SHAM, LEI ZHAO, ZIWEN ZHU, TANNER M. ROY, HUAPING XIAO, QIAN BAI, MARK R. WAKEFIELD and YUJIANG FANG

Anticancer Research July 2022, 42 (7) 3275-3284; DOI: https://doi.org/10.21873/anticanres.15816
Open Access
Intradural Extramedullary Spinal Metastases from Non-neurogenic Primary Tumors: A Systematic Review
PAOLO PALMISCIANO, ANDREW L. CHEN, MAYUR SHARMA, OTHMAN BIN-ALAMER, GIANLUCA FERINI, GIUSEPPE E. UMANA, SALAH G. AOUN and ALI S. HAIDER

Anticancer Research July 2022, 42 (7) 3251-3259; DOI: https://doi.org/10.21873/anticanres.15814
Open Access
The Role of Toll-like Receptors in Esophageal Cancer
SPYRIDON DAVAKIS, ALKISTIS KAPELOUZOU, THEODOROS LIAKAKOS, MARIA MPOURA, DIMITRIOS STERGIOU, STRATIGOULA SAKELLARIOU and ALEXANDROS CHARALABOPOULOS

Anticancer Research June 2022, 42 (6) 2813-2818; DOI: https://doi.org/10.21873/anticanres.15762
Open Access
Adverse Events in Placebo Arms of Cancer Trials
JOHANNES E. WOLFF, BIRTE J. WOLFF, MARCEAL M. THIELEN and HOLGER HAUCH

Anticancer Research June 2022, 42 (6) 2805-2812; DOI: https://doi.org/10.21873/anticanres.15761
Open Access
Exosomal Functional Cargoes from Liquid Biopsy of Gastric Cancer: A Systematic Review of Studies With Potential Clinical Relevance
EDOARDO VIRGILIO, FILIPPO MONTALI, ALFREDO ANNICCHIARICO, CARLO SALVEMINI, MANUEL BALDINU, ENRICO GIARNIERI, MONICA MONTAGNINI, SANDRA VILLANI, ANTONELLA PROIETTI, ROSARIA D’URSO and RENATO COSTI

Anticancer Research May 2022, 42 (5) 2249-2259; DOI: https://doi.org/10.21873/anticanres.15705
Open Access
Molecular Stratification of Medulloblastoma: Clinical Outcomes and Therapeutic Interventions
TOLGA SURSAL, JENNIFER S. RONECKER, ALIS J. DICPINIGAITIS, AVINASH L. MOHAN, MICHAEL E. TOBIAS, CHIRAG D. GANDHI and MEENA JHANWAR-UNIYAL

Anticancer Research May 2022, 42 (5) 2225-2239; DOI: https://doi.org/10.21873/anticanres.15703
Open Access
The Implication of X-Linked Genetic Polymorphisms in Susceptibility and Sexual Dimorphism of Cancer
CHAROULA ACHILLA, THEODOSIOS PAPAVRAMIDIS, LEFTERIS ANGELIS and ANTHOULA CHATZIKYRIAKIDOU

Anticancer Research May 2022, 42 (5) 2261-2276; DOI: https://doi.org/10.21873/anticanres.15706

Main menu

User menu

Search

More articles from Review

Pages